METRIC LABELING COMPLIANCE TO BE MONITORED BY FDA AFTER NOV. 8, 1994
This article was originally published in The Gray Sheet
Executive SummaryMETRIC LABELING COMPLIANCE TO BE MONITORED BY FDA AFTER NOV. 8, 1994, the agency says in a Dec. 21 proposed rule on metric content labeling for over-the-counter devices and other OTC products regulated by FDA. The agency says it "generally will not commit resources to monitoring compliance with the final rules resulting from this proposal until after Nov. 8, 1994." Before that time, "FDA believes that it would be inefficient to commit its limited resources to monitoring for enforcement purposes."
You may also be interested in...
A collaboration between Novo and Fauna will look at animal hibernation and genetic sequencing for hints toward novel therapies for obesity. Pfizer will use Insilico’s machine learning technology in target validation.
The introduction of gene therapies has been the highest-profile new modality to reach the market, but new RNA-based therapeutics hold significant potential and could be more accessible for patients. Scrip reviews the leading drug developers in this space.